genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2015
Tekmira Pharmaceuticals
Industry News
Tekmira and OnCore Tie the Knot, Plan to Focus on HBV Treatment
News
Tekmira, Monsanto Sign Development Agreement
News
Tekmira Wins $5M Milestone from Alnylam as Patisiran Enters Phase III
Industry News
Alnylam Losses Widened by Tekmira Settlement
News
Tekmira Gains License to an RNAi Technology
News
Burying the Hatchet: Alnylam Settles Tekmira RNAi Suits
Insights
Embattled RNAi Technology Tries New Tack
Cancer
BMS Expands Deal to Evaluate Tekmira’s RNAi Delivery Technology
Infectious Diseases
Tekmira Nabs License to Alnylam IP to Develop Ebola Virus Therapy Funded by U.S. Govt
Infectious Diseases
Tekmira Wins $34.7M Award to Develop RNAi Therapeutic against Ebola Virus
1
2
Page 1 of 2
Scroll Up
Scroll Up
